Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Maegdefessel

Showing results (1-10 of 208) with videos related to

Pageof 21
Sort By:
Current Vascular Pharmacology|July 10, 2015
Editorial: Therapeutic Potential of microRNAs in Vascular DiseaseLars Maegdefessel
Current Vascular Pharmacology|May 30, 2013
Therapeutic Potential of MicroRNAs in Vascular DiseaseLars Maegdefessel
European Heart Journal|May 11, 2023
Targeting non-coding RNAs for novel treatment strategies in vascular diseasesHanna Winter, Lars Maegdefessel
Annals of Translational Medicine|May 11, 2016
My heart will go on-beneficial effects of anti-MiR-30 after myocardial infarctionYuhuang Li, Lars Maegdefessel
Frontiers in Physiology|July 4, 2017
Non-coding RNA Contribution to Thoracic and Abdominal Aortic Aneurysm Disease Development and ProgressionYuhuang Li, Lars Maegdefessel
Arteriosclerosis, Thrombosis, and Vascular Biology|December 5, 2024
Long Non-Coding RNA Function in Smooth Muscle Cell Plasticity and AtherosclerosisLars Maegdefessel, Francesca Fasolo
European Heart Journal|September 5, 2025
Sugar, stress, and the arterial wall: a metabolic link in aortic aneurysmsFelix Kirchhoff, Lars Maegdefessel
Circulation. Cardiovascular Genetics|August 6, 2017
Towards Point-of-Care Measurements Using Noncoding RNAs: A Novel Tool to Monitor Aggravation of Advanced Atherosclerotic LesionsValentina Paloschi, Lars Maegdefessel
Frontiers in Physiology|March 3, 2020
Editorial: Entering the RNA Wonderland: Opportunities and Challenges for RNA Therapeutics in the Cardiovascular SystemAnna Zampetaki, Lars Maegdefessel
European Heart Journal|December 19, 2019
Linking obesity with abdominal aortic aneurysm developmentHans-Henning Eckstein, Lars Maegdefessel
Pageof 21

Showing results (1-10 of 208) with videos related to

Sort By:
Pageof 21
Current Vascular Pharmacology|July 10, 2015
Editorial: Therapeutic Potential of microRNAs in Vascular DiseaseLars Maegdefessel
Current Vascular Pharmacology|May 30, 2013
Therapeutic Potential of MicroRNAs in Vascular DiseaseLars Maegdefessel
European Heart Journal|May 11, 2023
Targeting non-coding RNAs for novel treatment strategies in vascular diseasesHanna Winter, Lars Maegdefessel
Annals of Translational Medicine|May 11, 2016
My heart will go on-beneficial effects of anti-MiR-30 after myocardial infarctionYuhuang Li, Lars Maegdefessel
Frontiers in Physiology|July 4, 2017
Non-coding RNA Contribution to Thoracic and Abdominal Aortic Aneurysm Disease Development and ProgressionYuhuang Li, Lars Maegdefessel
Arteriosclerosis, Thrombosis, and Vascular Biology|December 5, 2024
Long Non-Coding RNA Function in Smooth Muscle Cell Plasticity and AtherosclerosisLars Maegdefessel, Francesca Fasolo
European Heart Journal|September 5, 2025
Sugar, stress, and the arterial wall: a metabolic link in aortic aneurysmsFelix Kirchhoff, Lars Maegdefessel
Circulation. Cardiovascular Genetics|August 6, 2017
Towards Point-of-Care Measurements Using Noncoding RNAs: A Novel Tool to Monitor Aggravation of Advanced Atherosclerotic LesionsValentina Paloschi, Lars Maegdefessel
Frontiers in Physiology|March 3, 2020
Editorial: Entering the RNA Wonderland: Opportunities and Challenges for RNA Therapeutics in the Cardiovascular SystemAnna Zampetaki, Lars Maegdefessel
European Heart Journal|December 19, 2019
Linking obesity with abdominal aortic aneurysm developmentHans-Henning Eckstein, Lars Maegdefessel
Pageof 21